CLINICAL_TRIALS
trial_result
· 2013-02-04
Clinical Trial Update: A Phase II/III Study of SEP-190 (Eszopiclone) in Patients With Primary Insomnia (Study 190-126) [Phase 2, Phase 3]
Summary
Updates on a Phase II/III trial of SEP-190 (eszopiclone) for primary insomnia, with results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eisai Co., Ltd. | Conditions: Primary Insomnia | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2013-02-04